Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, the Department of Surgery, and the Armstrong Institute for Patient Safety and Quality, Johns Hopkins Hospital, Baltimore, Maryland; the University of California San Diego Medical Group, La Jolla, and the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine, Irvine, California; and the Division of Health Care Policy & Research and the Division of Gynecologic Surgery, Mayo Clinic, Rochester, Minnesota.
Corresponding author: Amanda N. Fader, MD, 600 N Wolfe Street, Phipps 281 Baltimore, MD 21287; e-mail: [email protected].
Supported by Sharon and Gregory Peters, Johns Hopkins Medicine, and the Ina Tornberg-Smith Endometrial Cancer Research Fund, Johns Hopkins Medicine.
Financial Disclosure The authors did not report any potential conflicts of interest.
Presented at the Society of Gynecologic Oncology Annual Meeting for Women's Cancers, March 28–31, 2015, Chicago, IL.